Trial Profile
A Single-center, Double-blind, Randomized, Placebo- and Positive-controlled, Parallel-group, Multiple-dose, Up-titration Study of the Electrocardiographic Effects of Ponesimod in Healthy Male and Female Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 24 Aug 2020
Price :
$35
*
At a glance
- Drugs Ponesimod (Primary)
- Indications Graft-versus-host disease; Multiple sclerosis; Plaque psoriasis
- Focus Adverse reactions
- Sponsors Actelion Pharmaceuticals
- 16 May 2014 New trial record